Abstract
These results indicate that the combination of HBV vaccine adjuvant and SPD induces a stronger humoral and cellular immune response through T-cell activation. These treatments may support the development of a strategy to completely eliminate HBV.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have